Drug Trial Radar · NCT05865431
Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light
Last checked: Nov 19, 2026Latest source record: Apr 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
17
Actual
Start
Mar 17, 2017
Primary completion
Feb 2, 2018
Study completion Feb 2, 2018
Sponsor
- Lead sponsor
- University of California, DavisAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 18, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is quantification of singlet oxygen species in the skin after exposure to Ultraviolet A (UVA) light
Conditions
- Sun Damaged Skin
Interventions
Zinc Oxide and AvobenzoneDrug
Zinc Oxide is applied to one area of the forearm, Avobenzone is applied to another area of the forearm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Amount of singlet oxygen generated by the left forearm skin (2 cm^2) after exposure to UVA radiation dose of 0.33 J/cm2Time frame: 5 minutes at first visit
- Amount of singlet oxygen generated by the left forearm skin (2 cm^2) after exposure to UVA radiation dose of 8.25 J/cm2Time frame: 5 minutes at first visit
- Amount of singlet oxygen generated by the left forearm skin (2 cm^2) after exposure to UVA radiation dose of 16.5 J/cm2Time frame: 5 minutes at first visit
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California, Davis
Sacramento, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.